SILO Stock Overview
Silo Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Silo Pharma, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.97 |
| 52 Week High | US$3.05 |
| 52 Week Low | US$1.22 |
| Beta | 1.35 |
| 1 Month Change | 12.57% |
| 3 Month Change | 42.71% |
| 1 Year Change | -8.80% |
| 3 Year Change | -84.85% |
| 5 Year Change | -90.15% |
| Change since IPO | -98.32% |
Recent News & Updates
Shareholder Returns
| SILO | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 4.2% | -4.2% | -3.7% |
| 1Y | -8.8% | -2.0% | 20.5% |
Return vs Industry: SILO underperformed the US Biotechs industry which returned -1.7% over the past year.
Return vs Market: SILO underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| SILO volatility | |
|---|---|
| SILO Average Weekly Movement | 7.1% |
| Biotechs Industry Average Movement | 11.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SILO's share price has been volatile over the past 3 months.
Volatility Over Time: SILO's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 3 | Eric Weisblum | silopharma.com |
Silo Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. The company’s developing solutions to address various underserved conditions.
Silo Pharma, Inc. Fundamentals Summary
| SILO fundamental statistics | |
|---|---|
| Market cap | US$5.60m |
| Earnings (TTM) | -US$3.63m |
| Revenue (TTM) | US$72.10k |
77.7x
P/S Ratio-1.5x
P/E RatioIs SILO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SILO income statement (TTM) | |
|---|---|
| Revenue | US$72.10k |
| Cost of Revenue | US$5.84k |
| Gross Profit | US$66.26k |
| Other Expenses | US$3.70m |
| Earnings | -US$3.63m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.28 |
| Gross Margin | 91.90% |
| Net Profit Margin | -5,036.04% |
| Debt/Equity Ratio | 0% |
How did SILO perform over the long term?
See historical performance and comparison